NephroGenex, Inc. — Form D
NephroGenex, Inc. of RALEIGH, NC, a company, filed a Form D exempt-offering notice with the SEC on 2015-11-13. The offering totals $28.5M, of which $5.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2015-11-13
- Form: D
- Accession: 0001338095-15-000070
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $28.5M
- Amount sold: $5.5M
- Remaining: $23.0M
- Investors: 14
- Date of first sale: 2015-11-03
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-251166
Issuer
- Name: NephroGenex, Inc.
- CIK: 0001338095
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 3200 BEECHLEAF COURT, RALEIGH, NC, 27604
- Phone: (609) 986-1780
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| PIERRE LEGAULT | Director | GREAT ABINGTON, CAMBRIDGE, X0 |
| Richard Markham | Director | Raleigh, NC |
| James Mitchum | Director | Raleigh, NC |
| Robert Seltzer | Director | New York, NY |
| Eugen Steiner | Director | Raleigh, NC |
| Marco Taglietti | Director | NY, NY |
| John Hamill | Executive Officer | St. Helier, Y9 |
| PIERRE LEGAULT | Executive Officer | GREAT ABINGTON, CAMBRIDGE, X0 |
| Jaikrishna Patel | Executive Officer | Raleigh, NC |
| Richard J Markham | Director | Princeton, NJ |
| J. Wesley Fox | Director | Princeton, NJ |
| J. Wesley Fox | Executive Officer | Princeton, NJ |
| Eugen R Steiner | Director | Princeton, NJ |
| David R Ramsay | Director | Princeton, NJ |
| Mark R Leschly | Director | Princeton, NH |
Other filings by this issuer (1)
More